SCHEMBL23958161

SCHEMBL23958161

COc1cncc(-n2c(Nc3cccnc3)nc3ccc(F)cc3c2=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.43
CYP19A1 P11511 1/20 0.41
G6PD P11413 1/20 0.41
ABCG2 Q9UNQ0 5/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
ABCB1 P08183 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
ALPL P05186 1/20 0.39
ALOX12 P18054 1/20 0.38
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23064661 0.92 CYP11B1 (0.42) CYP11B1CYP11B2MEN1USP2ALDH1A1
SCHEMBL24110985 0.91 G6PD (0.50) PIK3CDCYP19A1G6PDABCG2MEN1
SCHEMBL23958196 0.91 ADORA2A (0.49) PIK3CDCYP19A1ABCG2ADORA2AADORA1
SCHEMBL23958162 0.89 PIK3CD (0.44) PIK3CDABCG2ALOX12CYP1A2KMT2A
SCHEMBL24110949 0.88 HTR7 (0.44) MEN1USP2ALDH1A1CYP1A2CYP3A4
SCHEMBL23958245 0.88 PIK3CD (0.50) PIK3CDCYP11B2ALOX12ALDH1A1CYP1A2
SCHEMBL30103245 0.88 PIK3CD (0.50) PIK3CDCYP11B2ALOX12ALDH1A1CYP1A2
SCHEMBL23958265 0.86 PIK3CD (0.46) PIK3CDABCG2ALOX12KMT2A
SCHEMBL24110971 0.86 POLB (0.46) PIK3CDABCG2KMT2A
SCHEMBL29738614 0.86 PIK3CD (0.46) PIK3CDABCG2ALOX12KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 PIK3CD 3088/4885CYP19A1 2573/4885G6PD 1971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.